Research Facility

Toronto, Ontario M5G 2O4

1 studies enrolling now · 6 studies all time

What they study most

Advanced Breast Cancer, Arrhythmias, Carcinoid, Carcinoid Tumor, ER+ Breast Cancer, GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, HER2-negative Breast Cancer, Metastatic Breast Cancer, Neuroendocrine Tumors, Pancreatic NET

Studies at this site

• Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. — Recruiting now
• Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy — Recruiting now
• Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs. — Running, not enrolling
• Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs) — Completed
• A Comparison of Once a Day Dose Compared to 2 Doses/Day — Completed
• A Double Blind Study for the Treatment of Acute Ulcerative Colitis — Completed